Munson Medical Center
- Type
- Teaching hospital
- Where
- Traverse City, MI
- Medicare CCN
- 230097
- Received
- $348,981 in 53 records, 2024 ($13,314 general, $335,666 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: MUNSON MEDICAL CENTER,CORPORATION Fuzzy (name and state)
- Nonprofit contractor: MUNSON MEDICAL CENTER Fuzzy (name and state)
- Plan sponsor: MUNSON MEDICAL CENTER Fuzzy (name and state)
- Federal award recipient: MUNSON MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: MUNSON MEDICAL CENTER Fuzzy (name and state)
- Nonprofit: MUNSON MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2024 | General payment | 19 | $13,314 |
| 2024 | Research payment | 34 | $335,666 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| MicroVention, Inc. | 15 | $125,137 | 2024 |
| AstraZeneca Pharmaceuticals LP | 2 | $107,077 | 2024 |
| Amgen Inc. | 2 | $49,561 | 2024 |
| Rapid Medical Ltd | 4 | $32,505 | 2024 |
| AtriCure, Inc. | 1 | $14,470 | 2024 |
| Tandem Diabetes Care, Inc. | 16 | $7,925 | 2024 |
| Stryker Corporation | 2 | $4,641 | 2024 |
| PFIZER INC. | 1 | $2,338 | 2024 |
| Imperative Care, Inc | 2 | $2,000 | 2024 |
| BIOTRONIK INC. | 5 | $1,762 | 2024 |
| Linvatec Corporation | 1 | $748 | 2024 |
| Medical Device Business Services, Inc. | 1 | $500 | 2024 |
| Abbott Laboratories | 1 | $315 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 34 | $335,666 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 16 | $7,925 |
| Long term medical supply or device loan | 3 | $5,389 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | Stryker Corporation | $4,500 | Long term medical supply or device loan | In-kind items and services | NA Device, INSTRUMENTS | 2024 | |
| 2024-12-31 | Stryker Corporation | $140 | Long term medical supply or device loan | In-kind items and services | COMFORTGEL Device, PATIENT HANDLING - PH | 2024 | |
| 2024-12-04 | Tandem Diabetes Care, Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-12-02 | Linvatec Corporation | $748 | Long term medical supply or device loan | In-kind items and services | SYSTEM 5000 Device, GENERAL SURGERY | 2024 | |
| 2024-11-26 | MicroVention, Inc. | $2,527 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-11-20 | MicroVention, Inc. | $2,527 | Research payment | Cash or cash equivalent | SOFIA EX 5F - 105CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-11-15 | Rapid Medical Ltd | $3,087 | Research payment | Cash or cash equivalent | TIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, Neurovascular | DISTALS Study USA | 2024 |
| 2024-11-07 | Imperative Care, Inc | $1,000 | Research payment | Cash or cash equivalent | ZOOM 88-T LARGE DISTAL PLATFORM Device, VASCULAR | 2024 | |
| 2024-10-30 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-10-24 | MicroVention, Inc. | $13,556 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-10-23 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-10-16 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-10-15 | Rapid Medical Ltd | $11,830 | Research payment | Cash or cash equivalent | TIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, Neurovascular | DISTALS Study USA | 2024 |
| 2024-10-04 | AtriCure, Inc. | $14,470 | Research payment | Cash or cash equivalent | ATRICLIP LAA EXCLUSION SYSTEM Device, CARDIOVASCULAR | LEFT ATRIAL APPENDAGE EXCLUSION FOR PROPHYLACTIC STROKE REDUCTION TRIAL | 2024 |
| 2024-10-03 | Imperative Care, Inc | $1,000 | Research payment | Cash or cash equivalent | ZOOM 88-T LARGE DISTAL PLATFORM Device, VASCULAR | 2024 | |
| 2024-09-18 | MicroVention, Inc. | $15,962 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-09-18 | MicroVention, Inc. | $1,000 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-09-11 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-09-03 | Rapid Medical Ltd | $500 | Research payment | Cash or cash equivalent | TIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, Neurovascular | DISTALS Study USA | 2024 |
| 2024-08-07 | Tandem Diabetes Care, Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-07-31 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-07-25 | MicroVention, Inc. | $10,787 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-07-22 | AstraZeneca Pharmaceuticals LP | $90,027 | Research payment | Cash or cash equivalent | A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato DXd) Plus Durvalumab Followed by A | 2024 | |
| 2024-07-10 | MicroVention, Inc. | $1,593 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-07-02 | Rapid Medical Ltd | $17,087 | Research payment | Cash or cash equivalent | TIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, Neurovascular | DISTALS Study USA | 2024 |
| 2024-06-27 | MicroVention, Inc. | $13,782 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-06-26 | BIOTRONIK INC. | $1,500 | Research payment | Cash or cash equivalent | Plexa ProMRI Device, Cardiology/Vascular Diseases | BIO-LIBRA | 2024 |
| 2024-06-20 | Tandem Diabetes Care, Inc. | $975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-05-29 | AstraZeneca Pharmaceuticals LP | $17,050 | Research payment | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | Dapagliflozin in Acute Decompensated Heart Failure | 2024 |
| 2024-05-22 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-05-16 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-05-15 | BIOTRONIK INC. | $181 | Research payment | Cash or cash equivalent | Solia Device, Cardiology/Vascular Diseases | BIO-LIBRA | 2024 |
| 2024-05-15 | BIOTRONIK INC. | $48 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | BIO-LIBRA | 2024 |
| 2024-05-15 | BIOTRONIK INC. | $16 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | BIO-LIBRA | 2024 |
| 2024-05-15 | BIOTRONIK INC. | $16 | Research payment | Cash or cash equivalent | Acticor 7 VR-T DX Device, Cardiology/Vascular Diseases | BIO-LIBRA | 2024 |
| 2024-05-08 | MicroVention, Inc. | $12,187 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-04-20 | Amgen Inc. | $22,960 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | 20170625_VESALIUS - CV | 2024 |
| 2024-04-03 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-03-27 | MicroVention, Inc. | $4,017 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-03-14 | MicroVention, Inc. | $5,054 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-03-13 | Tandem Diabetes Care, Inc. | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-03-12 | PFIZER INC. | $2,338 | Research payment | Cash or cash equivalent | A PHASE 2 DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED 4ARM STUDY TO INVESTIGATE SYMPTOMS FUNCTION HEALTHRELATED QUALITY OF | 2024 | |
| 2024-02-28 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-02-27 | Medical Device Business Services, Inc. | $500 | Research payment | Cash or cash equivalent | WaveCrest Vs. Watchman Transseptal LAA Closure to Reduce AF Mediated Stroke 2 | 2024 | |
| 2024-02-08 | Tandem Diabetes Care, Inc. | $850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-02-06 | Amgen Inc. | $26,601 | Research payment | In-kind items and services | Repatha Biological, Cardiology | 20170625_VESALIUS - CV | 2024 |
| 2024-02-01 | MicroVention, Inc. | $13,573 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-01-25 | MicroVention, Inc. | $2,753 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-01-24 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-01-18 | MicroVention, Inc. | $13,314 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-01-18 | MicroVention, Inc. | $12,500 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2024 |
| 2024-01-10 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-01-09 | Abbott Laboratories | $315 | Research payment | Cash or cash equivalent | Diamondback Coronary Device, VASCULAR | ECLIPSE | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Traverse City, MI, county Grand Traverse County, MI, state Michigan; placed by its city name.
| Measure | Place (city or town) Traverse City, MI | County Grand Traverse County, MI | State Michigan |
|---|---|---|---|
| Population B01003 | 15,593 | 96,166 | 10,077,761 |
| Population, 2020 census P1 | 15,678 | 95,238 | 10,077,331 |
| Median age B01002 | 42.7 | 43.5 | 40.2 |
| Under 18 B01001 | 16.6% | 19.4% | 21.2% |
| 65 and over B01001 | 23.9% | 22.0% | 18.6% |
| Households B11001 | 7,191 | 40,287 | 4,076,369 |
| Foreign born B05002 | 2.5% | 2.0% | 7.2% |
| Median household income B19013 | $74,087 | $81,647 | $72,875 |
| Median family income B19113 | $106,362 | $101,748 | $93,357 |
| Per capita income B19301 | $53,432 | $45,034 | $40,735 |
| Poverty rate B17001 | 12.3% | 9.6% | 13.2% |
| Unemployment rate B23025 | 5.2% | 3.8% | 5.7% |
| Civilian labor force B23025 | 8,267 | 50,787 | 5,018,449 |
| Mean commute (minutes) B08013 | 17.2 | 20.6 | 24.2 |
| Bachelor's degree or higher B15003 | 47.4% | 40.6% | 32.4% |
| Housing units B25001 | 8,479 | 47,003 | 4,622,236 |
| Owner-occupied B25003 | 63.7% | 77.2% | 73.2% |
| Renters B25003 | 36.3% | 22.8% | 26.8% |
| Median home value B25077 | $415,400 | $339,400 | $231,600 |
| Median gross rent B25064 | $995 | $1,288 | $1,129 |
| White, not Hispanic B03002 | 87.7% | 90.5% | 72.4% |
| Black B03002 | 1.3% | 0.8% | 13.1% |
| Hispanic or Latino B03002 | 3.6% | 3.4% | 5.9% |
| Asian B03002 | 1.1% | 0.7% | 3.4% |
| American Indian and Alaska Native B03002 | 0.2% | 0.4% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Traverse City, MI.
Comments